HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Cerles Selected Research

Catenins

11/2016Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
10/2016Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olivier Cerles Research Topics

Disease

6Neoplasms (Cancer)
11/2019 - 12/2014
6Fibrosis (Cirrhosis)
01/2018 - 10/2015
4Peripheral Nervous System Diseases (PNS Diseases)
11/2019 - 12/2014
3Colonic Neoplasms (Colon Cancer)
11/2019 - 01/2017
3Demyelinating Diseases (Demyelinating Disease)
11/2019 - 01/2017
3Systemic Scleroderma (Systemic Sclerosis)
11/2016 - 10/2015
3Inflammation (Inflammations)
10/2015 - 01/2015
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017 - 10/2016
2Graft vs Host Disease (Graft-Versus-Host Disease)
11/2016 - 10/2015
2Endometriosis
09/2015 - 01/2015
1Osteitis
01/2022
1Multiple Sclerosis
01/2019
1Parkinson Disease (Parkinson's Disease)
01/2019
1Carcinoma (Carcinomatosis)
02/2018
1Neuralgia (Stump Neuralgia)
01/2017
1Neuroinflammatory Diseases
01/2017
1Hyperalgesia
01/2017
1Hypesthesia (Numbness)
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Alopecia (Baldness)
11/2016
1Diarrhea
11/2016
1Vasculitis (Vasculitides)
11/2016
1Bronchiolitis Obliterans Syndrome
10/2015

Drug/Important Bio-Agent (IBA)

3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2019 - 01/2017
3Dimethyl FumarateIBA
02/2018 - 01/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2018 - 12/2014
3NiclosamideFDA Link
01/2017 - 10/2016
2PlatinumIBA
01/2019 - 01/2017
2AntioxidantsIBA
02/2018 - 01/2017
2Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2017 - 10/2016
2AnthelminticsIBA
11/2016 - 10/2016
2AutoantibodiesIBA
11/2016 - 10/2016
2CateninsIBA
11/2016 - 10/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Amoxicillin (Wymox)FDA LinkGeneric
01/2022
1FluoroquinolonesIBA
01/2022
1Superoxide DismutaseIBA
11/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1Benztropine (Benzatropine)FDA LinkGeneric
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Histamine (Histamine Dihydrochloride)FDA Link
01/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019
1CytokinesIBA
01/2019
1Platinum Compounds (Compounds, Platinum)IBA
01/2019
1Muscarinic M3 ReceptorIBA
01/2019
1Glutathione (Reduced Glutathione)IBA
02/2018
1Transcription Factors (Transcription Factor)IBA
02/2018
1AntibodiesIBA
01/2017
1Leflunomide (Arava)FDA LinkGeneric
01/2017
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2016
1pantetheinase (pantetheine hydrolase)IBA
10/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2016
1Minor Histocompatibility AntigensIBA
10/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2015
1raf KinasesIBA
09/2015
1Sorafenib (BAY 43-9006)FDA Link
09/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2015
1Mitogen-Activated Protein KinasesIBA
01/2015
1Contraceptive Agents (Contraceptives)IBA
01/2015
1Phosphotransferases (Kinase)IBA
01/2015

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2019 - 12/2014
2Therapeutics
01/2022 - 01/2015
1Cell Transplantation
11/2016
1Hematopoietic Stem Cell Transplantation
10/2015